CCA
AVNS

Clearwater Capital Advisors’s Avanos Medical AVNS Stock Holding History

Clearwater Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-49
Closed -$2K – 210
2018
Q1 		$2K Buy
+49
New +$2.33K ﹤0.01% 589

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Clearwater Capital Advisors's AVNS Position: Q2 2018 in Review

Clearwater Capital Advisors sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 49 shares — an estimated $2K sold.

Clearwater Capital Advisors first reported a position in AVNS in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

  • Clearwater Capital Advisors reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
  • Clearwater Capital Advisors sold 49 Avanos Medical shares in Q2 2018, an estimated $2K.
  • Clearwater Capital Advisors first reported a position in Avanos Medical in Q1 2018 and held it in 1 quarter.
  • Clearwater Capital Advisors's Avanos Medical position peaked at $2K in Q1 2018.
  • 321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on Clearwater Capital Advisors's 13F filing for Q2 2018, filed 16 Aug 2018.